Karen Flynnas been a Catalent board member since September 2022. Ms. Flynn retired in July 2022 from her position as Catalent’s Senior Vice President & Chief Commercial Officer. She joined Catalent as President, Biologics and Chief Commercial Officer in 2020. Before Catalent, she was Senior Vice President and Chief Commercial Officer for West Pharmaceutical Services, Inc. from 2016 to 2019 and served as its President of Pharmaceutical Packaging Systems from 2014. Ms. Flynn is also on the board of Quanterix Corporation and was a member of the board of directors for Recro Pharmaceuticals. She serves with the University of Notre Dame’s Hesburgh Women of Impact mentorship program and also has been on the Chester County Economic Development Council Board of Directors and the Downingtown STEM Academy Advisory Board. Ms. Flynn holds an MBA from Boston University, a master’s in engineering from the University of Pennsylvania, and a pre-med degree from the University of Notre Dame.